Clinical Trial Update: Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ribavirin to enhance hepatitis B nucleotide analogue antiviral activity is ongoing, with chronic hepatitis B as the conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Hepatitis B, Chronic | Phase 3 | Status: UNKNOWN